Asking the right questions: Measuring the impact of pharmacovigilance
October 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance
Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? …
Simplify your regulatory processes
October 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva
It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product variations, …
Trials reveal two strong vaccine candidates for Ebola
October 16, 2017Research and Development, Sales and Marketing Ebola, biotech, drugs, pharma, pharmaceutical
Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged. The two therapies …
FDA expands Janssen’s Stelara to cover adolescent psoriasis patients
October 16, 2017Sales and Marketing FDA, Janssen, Stelara, pharma, psoriasis
Janssen has announced that the FDA has approved an expanded indication for its psoriasis therapy Stelara (ustekinumab) for the treatment …
AstraZeneca admits cancer data for acquired drug was fabricated
October 16, 2017Research and Development, Sales and Marketing Acerta, AstraZeneca, acalabrutinib
AstraZeneca has revealed that early-stage data concerning the efficacy of its acquired drug acalabrutinib in the treatment of blood cancers …
Roche launches Warp Drive antibiotic collaboration for $387m
October 16, 2017Sales and Marketing Antibiotics, Roche, biotech, drugs, pharma, pharmaceutical
Roche had tentatively begun to re-enter the antibiotic space, but it has now signalled its growing intention to move in …
Top Ten most popular articles on Pharmafile.com this week
October 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, pharmaceuticals, top ten
It’s been another packed week in the industry, with one of the biggest takeaways being that childhood obesity has rocketed …
Breakthrough study could revolutionise MS treatment
October 13, 2017Medical Communications, Research and Development biotech, drugs, multiple sclerosis, pharma, pharmaceutical
The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from …
BMS agrees deal on Opdivo availability through Cancer Drugs Fund for head and neck cancer
October 13, 2017Sales and Marketing BMS, Bristol-Myers Squibb, CDF, Cancer Drugs Fund, NICE, opdivo, pharma, pharmaceutical
Thanks to successful negotiation of a managed access agreement, NICE has announced its recommendation of Bristol-Myers Squibb’s Opdivo (nivolumab) for …
Free Webinar: EudraVigilance changes and the impact on MAHs
October 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, eudravigilance, pharma, pharmaceutical, primevigilance
Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.
First leprosy vaccine makes initial step towards human use
October 13, 2017Medical Communications, Research and Development biotech, drugs, leprosy, pharma, pharmaceutical
A vaccine for leprosy, developed by the Infectious Disease Research Institute (IDRI) and with the financial support of the American …
Strong IBS and constipation Phase 3 data sends Ardelyx shares rocketing 60%
October 12, 2017Research and Development Ardelyx, pharma, pharmaceuticals, tenapanor
Ardelyx has confirmed that its NHE3 inhibitor tenapanor met all its primary and secondary endpoints in the study of its …
Epidemic preparedness: Protecting the world from the next infectious disease
October 12, 2017CEPI, biotech, drugs, pharma, pharmaceutical
Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness, details the lessons learned from the Ebola outbreak and the …
Aerie’s glaucoma drug gets strong preliminary FDA opinion
October 12, 2017Sales and Marketing Aerie, Aerie Pharmaceutical, FDA, Glaucoma, Rhopressa, pharma
In a preliminary review of the drug, the FDA has judged that Aerie Pharmaceutical’s experimental glaucoma treatment Rhopressa (netarsudil) effectively …
NICE gives final draft guidance on two key cancer drugs
October 12, 2017Sales and Marketing Bayer, CDF, Cancer, Cancer Drugs Fund, Erivedge, NICE, Roche, Stivarga
NICE has announced it has published its final draft guidance for two cancer treatments, covering Bayer’s Stivarga (regorafenib) in the …
MSD gives up on cholesterol drug, despite positive results
October 12, 2017Medical Communications, Sales and Marketing MSD, Merck, biotech, cholesterol, drugs, pharma, pharmaceutical
MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …
Sanofi set for €170 million expansion of vaccine facility
October 12, 2017Manufacturing and Production Sanofi, Sanofi Pasteur, biotech, drugs, influenza, pharma, pharmaceutical
Sanofi has announced that it plans to expand its vaccine manufacturing facility in Val de Reuil, France, with an injection …
Childhood obesity increased 10-fold over last four decades
October 11, 2017Research and Development biotech, drugs, obese, obesity, pharma, pharmaceutical
An analysis of childhood and teenage obesity levels around the world have revealed that the numbers who are considered dangerously …
Lupin scoops up women’s health specialist Symbiomix for $150 million
October 11, 2017Research and Development, Sales and Marketing India, Lupin, Lupin Pharmaceuticals, Symbiomix, US, acquisition, pharma
The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …
Moffitt scientists discover new applications for Novartis’s Zykadia
October 11, 2017Research and Development Cancer, Moffitt, NSCLC, ceritinib, lung cancer, zykadia
Through the use of molecular screening, functional proteomics and computer-based modelling, researchers from the Moffitt Cancer Center have been working …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
